Back to Search
MELVIN ZELEFSKY, MD
MD
Diagnostic Radiology Physician
NPI: 1558427088Individual
Specialties, Licenses & Credentials
Diagnostic Radiology PhysicianPrimary
Radiology — Diagnostic Radiology
Code: 2085R0202X
25MA02492600(NJ)
Research & Publications (20)
Postoperative nomogram predicting the 9-year probability of prostate cancer recurrence after permanent prostate brachytherapy using radiation dose as a prognostic variable.
PMID 19540064·Int J Radiat Oncol Biol Phys·2010
4-observational
Reirradiation of locally recurrent nasopharynx cancer with external beam radiotherapy with or without brachytherapy.
PMID 19467802·Int J Radiat Oncol Biol Phys·2010
8-other
High-dose-rate intraoperative radiation therapy for recurrent head-and-neck cancer.
PMID 19560882·Int J Radiat Oncol Biol Phys·2010
8-other
Volumetric modulated arc therapy: planning and evaluation for prostate cancer cases.
PMID 19540062·Int J Radiat Oncol Biol Phys·2010
4-observational
Role of external beam radiotherapy in patients with advanced or recurrent nonanaplastic thyroid cancer: Memorial Sloan-kettering Cancer Center experience.
PMID 18676097·Int J Radiat Oncol Biol Phys·2009
8-other
The current state of brachytherapy nomograms for patients with clinically localized prostate cancer.
PMID 19544540·Cancer·2009
6-review
Using QRRO survey data to assess compliance with quality indicators for breast and prostate cancer.
PMID 19467491·J Am Coll Radiol·2009
8-other
Regarding the focal treatment of prostate cancer: inference of the Gleason grade from magnetic resonance spectroscopic imaging.
PMID 18990509·Int J Radiat Oncol Biol Phys·2009
8-other
Multicenter analysis of effect of high biologic effective dose on biochemical failure and survival outcomes in patients with Gleason score 7-10 prostate cancer treated with permanent prostate brachytherapy.
PMID 18597953·Int J Radiat Oncol Biol Phys·2009
4-observational
Postradiotherapy 2-year prostate-specific antigen nadir as a predictor of long-term prostate cancer mortality.
PMID 19515504·Int J Radiat Oncol Biol Phys·2009
8-other
Clinical and pathologic prognostic features in acinic cell carcinoma of the parotid gland.
PMID 19309749·Cancer·2009
8-other
Multicenter phase 2 study of neoadjuvant paclitaxel, estramustine phosphate, and carboplatin plus androgen deprivation before radiation therapy in patients with unfavorable-risk localized prostate cancer: results of Cancer and Leukemia Group B 99811.
PMID 18989865·Cancer·2008
3-trial
Long-term neck control rates after complete response to chemoradiation in patients with advanced head and neck cancer.
PMID 18838883·Am J Clin Oncol·2008
8-other
Which patients with prostate cancer benefit from immediate postoperative radiotherapy?
PMID 18382431·Nat Clin Pract Oncol·2008
8-other
A multi-institutional matched-control analysis of adjuvant and salvage postoperative radiation therapy for pT3-4N0 prostate cancer.
PMID 18672274·Urology·2008
4-observational
Dosimetric and anatomic indicators of late rectal toxicity after high-dose intensity modulated radiation therapy for prostate cancer.
PMID 18561689·Med Phys·2008
8-other
Unresectable carcinoma of the paranasal sinuses: outcomes and toxicities.
PMID 18395361·Int J Radiat Oncol Biol Phys·2008
8-other
What is the role of androgen deprivation therapy in the treatment of locally advanced prostate cancer?
PMID 18813218·Nat Clin Pract Urol·2008
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 652 WINTHROP RD
TEANECK, NJ 07666 - Phone
- (201) 836-5226
Quick Facts
- NPI
- 1558427088
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile